News

17

Apr, 2019

Global Health Festival, Padova, 5th-7th April

 

On April 5th-7th Padova (Italy) hosted the Global Health Festival. The aim of the festival was to investigate scientific progress and explore technological advances and policies that let the right to health to be increasingly universal and inclusive, in every corner of the world.

READ MORE

4

Apr, 2019

SMILE Clinical Trial: 100th Patient Enrolled

Tags: , ,

The Penta-sponsored clinical trial SMILE has achieved a significant milestone by recruiting its 100th patient yesterday. The patient was enrolled at the Perinatal HIV Research Unit (PHRU) in Soweto, South Africa.  This is a wonderful result achieved through hard work and cooperation among the sites, the CTUs and the sponsor.

READ MORE

1

Apr, 2019

Launch of VALUE-Dx in Madrid marked with press release

 

The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitrodiagnostic companies who join forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. Coordinated by the University of Antwerp, the ambition of VALUE-Dx is to transform medical practice to achieve more personalised, evidence-based antibiotic prescription and use in community care settings through the widespread use of clinical and cost-effective innovative diagnostic strategies. VALUE-Dx is co-funded by the European Commission (IMI), the Wellcome Trust and private companies over a 4 year period.

READ MORE

21

Mar, 2019

c4c Call for tender – Business school

 

The c4c consortium has issued a call for tender for subcontracting a specialised business school or company that can assist in the development of a sustainable business model for a pan-European paediatric clinical trials network. An important element of c4c is the push for a well-functioning business model and long-term sustainability, making sure that the network will continue to assume its pivotal function in a this way.

READ MORE

18

Mar, 2019

The Global Health Festival, Padova, 5th-7th April

Tags: ,

The first edition of the Global Health Festival (‘Festival della Salute Globale’) is to take place in Padova, Italy on 5th-7thApril 2019. In partnership with Comune di Padova, Università degli Studi di Padova and Medici con l’Africa CUAMM, the event will take an unconventional look at the fundamental issues concerning global health today. Through an interactive programme, the public is invited to consider the broader social, environmental, economic and cultural conditions when evaluating the health of an individual or community.

READ MORE

15

Mar, 2019

CROI 2019: Oral presentation by members of the EPIICAL team

Tags: , ,

The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held on 4-7 March 2019, at the Washington State Convention Center in Seattle, Washington. At this year’s event, EPIICAL team member Sara Dominguez Rodriguez delivered an engaging oral presentation on the earliest antiretroviral therapy initiation in infants.

READ MORE

14

Mar, 2019

ODYSSEY poster presentation at CROI 2019

 

The ODYSSEY project team members Pauline Bollen and Anna Turkova successfully presented a poster with the results of an important pharmacokinetic sub-study on the use of adult Dolutegravir 50mg tablets in children living with HIV and weighing 20-25kg. The poster session took place at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.

READ MORE

4

Mar, 2019

GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

Tags: , ,

Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.

READ MORE